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Improving services for glaucoma care in Nigeria:
implications for policy and programmes to achieve
universal health coverage
Fatima Kyari,1,2 Clare Gilbert,1 Karl Blanchet,3 Richard Wormald1,4
ABSTRACT
Glaucoma in Africa is sometimes referred to as the silent
thief of sight. In Nigeria, glaucoma is common, it is
serious, ophthalmologists face many constraints in
managing it, people do not even know they have it until
it is advanced, patients do not understand or comply
with treatment after they are diagnosed and the poor
are more likely to be glaucoma blind. Available evidence
indicates that the health system in Nigeria is failing to
meet the needs of patients with glaucoma. Based on
evidence, we propose future directions for improving
services for glaucoma care in Nigeria, and the
implications for policy and programmes to control
glaucoma blindness, using a health system-oriented
approach. Three complementary strategies are required:
(i) strengthening clinical services for glaucoma—by
developing models of glaucoma care, improving clinical
treatment options, making medicines and equipment
available, ﬁnancing glaucoma care and training eye care
workers; (ii) introducing initiatives for earlier detection of
glaucoma in the clinic and approaches in the community
and (iii) strengthening health system governance.
Glaucoma is a complex disease to manage and
addressing it as a public health problem is challenging.
However, we need to change the paradigm to recognise
that glaucoma is a potentially avoidable cause of
blindness in Africa.
INTRODUCTION
The United Nations resolution on Universal Health
Coverage (UHC) is fundamental to achieving sus-
tainable development goal no. 3—equity in health
for everyone. This entails improving access to
quality health services and protection against ﬁnan-
cial risks in accessing services.1 In line with UHC, a
Global Action Plan 2014–2019 was developed for
eye care,2 which aims to ensure that eye diseases
that cause blindness and visual impairment are
addressed through universal standards of eye care
that address local priorities.
Glaucoma is a group of eye diseases characterised
by progressive optic neuropathy with visual ﬁeld
loss which can lead to irreversible blindness.
Glaucoma affected more than 64.3 million globally
in 2013, and is projected to increase to 76 million
by 2020.3 Primary open angle glaucoma is the most
common type, affecting 57.5 million people in
2015, increasing to 65.5 million by 2020.4
Glaucoma in Africa is sometimes referred to as
the silent thief of sight,5 and available evidence
indicates that the health system in Nigeria is failing
to meet the needs of patients with glaucoma. Based
on our ﬁndings6–10 (summarised in ﬁgure 1), we
propose future directions for improving services
for glaucoma care in Nigeria, and the implications
for policy and programmes to control glaucoma
blindness, using a health system-oriented approach.
Some of our recommendations also derive from
major meetings on glaucoma in Africa: The Africa
Glaucoma Summit in Accra, Ghana (2010)11 and
the Public Health Control of Vision Loss from
Glaucoma in Africa Workshop in Kampala, Uganda
(2012)12 as well as relevant publications.13 14 The
strategy we recommend is to target those in greatest
need for glaucoma care to prevent them from
going blind, supported by policies and funding
mechanisms for service delivery, and clinical and
operational research. At the same time, there is a
need for health partnerships and social policies to
address poverty through improved education and
literacy, entrepreneurship and wealth creation.
GLAUCOMA IN NIGERIA
Data from the 2009 Nigeria national blindness and
visual impairment survey (thereafter referred to as
the Nigeria Blindness Survey) indicated that 4.2%
of adults aged 40 years and above were blind.15
Glaucoma was the second most common cause of
blindness (16.7%),16 principally open angle glau-
coma (OAG) (86% of all glaucoma).6 In 2009, 5%
of survey participants had glaucoma, affecting an
estimated 1.8 million adults, and one in ﬁve was
blind that is, had a presenting visual acuity (VA) of
<3/60 in the better eye. Ninety-four per cent were
not diagnosed and not receiving care.6 Independent
risk factors for OAG were higher intraocular pres-
sure, increasing age and Igbo ethnicity.7 People of
low socioeconomic status were approximately four
times more likely to be blind from glaucoma,8
reﬂecting limited awareness of glaucoma and poor
access to care. Additionally, ophthalmologists face
many constraints in managing it.9
From the Nigeria Blindness Survey, it is estimated
that per million population, 10 500 adults (aged
40 years and above) have glaucoma. The following
deﬁnitions were used to estimate the number
affected by level of severity, using the most affected
eye: severe/advanced glaucoma—VA <3/60, vertical
cup:disc ratio (VCDR) >0.8 and central visual ﬁeld
(CVF) of <10°; moderate glaucoma—any level of
VA with VCDR >0.7 and CVF of 10–20°; early/
mild glaucoma—any glaucomatous visual ﬁeld
defect and VCDR ≥0.7. Blind/end-stage glaucoma
was deﬁned as VA <3/60 in the better eye with a
VCDR of 1.0.17 There are estimated to be 5900
(56%) adults per million population with severe/
advanced disease, often blind in one eye and/or
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with severe visual impairment in the other eye, 2100 (20%)
moderate cases, 400 (4%) early cases and a further 2100 (20%)
are blind in both eyes.
Several factors contribute to the high prevalence of glaucoma
blindness in Nigeria. These include low rates of early detection
and diagnosis,17 lack of specialist equipment and treatment
options, lack of specialist glaucoma clinics and care pathways,
poor compliance with treatment and follow-up,9 the high cost
of accessing care and treatment costs18 and lack of awareness
and public knowledge about glaucoma compounded by socio-
economic deprivation.10 The number of eye health workers in
Nigeria, including ophthalmologists and optometrists, falls
short of WHO recommendations.19 20 In addition, Nigeria
does not have an eye health policy and the national strategic
plan for eye care is not uniformly implemented.
Considering these factors, three complementary strategies
need to be put in place to reduce glaucoma blindness: (i)
strengthening clinical services for glaucoma; (ii) introducing
initiatives for earlier detection of glaucoma and (iii) strengthen-
ing health system governance.
STRENGTHENING CLINICAL SERVICES FOR GLAUCOMA
Developing models of glaucoma care
There are currently no published articles on models of glaucoma
care in Africa. A conceptual framework and systems approach
for improving services for glaucoma in Nigeria are shown in
ﬁgure 1. Clinical, operational and health system research need
to be embedded in care delivery models to determine optimal
ways to improve access and acceptance of cost-effective treat-
ment, to improve patients’ hospital experiences and compliance
rates, to promote follow-up of patients with stable disease in
district eye departments and for the earlier detection of glau-
coma in the community.
Improving clinical treatment options
The treatment recommended for glaucoma in Africa depends
on several factors. Medical therapy is often the ﬁrst-line of
treatment, with β-blockers and prostaglandin analogues (PGAs)
being available to prescribe by at least 97% of ophthalmologists
in Nigeria.9 PGAs are effective in preventing progression of
visual ﬁeld loss in the UK population,21 but their use in
Nigeria is limited due to their high cost. Other constraints
include poor compliance with medicines and uncertain potency
of topical preparations, which are usually kept in high ambient
temperatures. One-off interventions are recommended in
Africa, one being primary trabeculectomy with antimetabolites
or β-irradiation, with a suggested ‘glaucoma surgical rate’ of
800 glaucoma surgeries per million population per year.22
Indeed, skilful trabeculectomy with a joint care plan and
adequate follow-up may be a good option but acceptance of
surgery can be very low.9 17 Laser therapy seems a safe and
acceptable alternative, which reduces costs to patients, as an
inpatient stay is not required. Although the initial capital
outlay for lasers is high, they can be used to treat other eye
conditions, and can function for many years. An effective, safe,
affordable and acceptable one-off treatment is the ﬁrst essential
building block of glaucoma care in Africa, particularly for the
poor and illiterate and those who live far from eye care facil-
ities. Treatment modalities need to be assessed in randomised
controlled trials to determine the most cost-effective and
acceptable treatment for patients and providers in the African
context.
Making medicines, surgery and laser treatment available
To improve access to treatment, institutions need to be strength-
ened with equipment and training in surgical skills and laser
procedures, with the development of glaucoma care teams.
Tertiary institutions should have specialist glaucoma clinics that
are adequately resourced so that a full assessment and deﬁnitive
diagnosis can be made at the ﬁrst visit, with counselling of
patients and their carers about treatment and the need for long-
term follow-up.
Relevant government ministries/agencies are urged to improve
the supply chain of glaucoma medications and surgical consum-
ables through tax and import duty waivers, and by providing an
enabling environment for local production of glaucoma medica-
tion. Pharmaceutical companies could be called on to provide
non-branded PGAs which may be made affordable and provided
free of charge to the poorest through government’s UHC
mechanisms, and global technology partners should make lasers
and accessories (lenses, probes, protective goggles, etc) more
affordable for service providers in low-income and
middle-income countries.
Financing glaucoma care
No patient should receive suboptimal care because he or she
cannot afford treatment. Strategies for healthcare ﬁnancing for
glaucoma to contain costs need to be developed and evaluated.
One approach could be to provide free treatment to poor
patients. Another is to advocate that more potent medications
such as PGAs, and trabeculectomy and laser procedures be
covered by health insurance. UHC through government budget-
ary allocations is probably the most sustainable approach for
such a chronic, serious and lifelong disease.
Human resources for eye health
In order to improve services for glaucoma, multitasking by
health workers is recommended with, for example, nurses being
trained to perform optic nerve head photography and visual
ﬁeld analysis. Early detection of signiﬁcant glaucoma through
community-based opportunistic case detection by optometrists,
follow-up in the community and community-based care espe-
cially for postoperative cases by ophthalmic nurses and testing
for vision loss by primary healthcare workers are also strategies
to explore. Agreement on professional boundaries will be
required, with clearly deﬁned work areas for allied eye care
members of the glaucoma care team, and clearly deﬁned roles
for glaucoma care in secondary centres.23
Health information system
Health management information systems are essential for
improving glaucoma services in Nigeria to provide good
medical records systems to track patients over time and monitor
trends of treatment. We recommend that the number of proce-
dures for glaucoma, as well as the number of cataract opera-
tions, should be monitored and reported centrally. Good
medical records are also important for robust referral/feedback
systems, to document clinical ﬁndings for follow-up and to
develop a database of patients with glaucoma.
APPROACHES FOR EARLIER DETECTION OF GLAUCOMA
Before starting any intervention for case detection, adequate
clinical services for glaucoma must be in place. The challenge of
a public health glaucoma care programme would be to ﬁnd
people who already have signiﬁcant glaucoma and ensure they
have access to services to reduce the risk of progression to
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bilateral blindness. The poorest in the population need to be tar-
geted because glaucoma blindness affects them the most.
In the clinic
Primary eye care, including that provided by optometrists who
are few in number and usually located in urban areas, is almost
entirely lacking in Nigeria, as in many countries in Africa, and
so there are no mechanisms for early detection of glaucoma.
One solution to improve earlier detection of glaucoma is to
ensure that all adults aged 40 years and above who present to
eye care services, regardless of their presenting complaint,
undergo routine optic disc assessment. This approach was
effective in the eye department in Bauchi, North-Eastern
Nigeria, where the optometrists referred anyone with a CDR
≥0.6 to the ophthalmologist for examination.17
Identiﬁed high-risk groups and ﬁrst-degree relatives of
patients with glaucoma should also be targeted.
Community approaches
We advocate that optic disc assessment of all those aged
40 years and above become an integral component of outreach
eye care activities with a referral of those with VCDR ≥0.6 to
designated facilities for full assessment, deﬁnitive diagnosis and
treatment. Another assessment to consider at the community
level is a properly conducted swinging ﬂashlight test to detect
relative afferent pupillary defects, which has the potential to
ﬁnd at least 25% of glaucoma,24 and with strong speciﬁcity for
glaucoma.25
Figure 2 shows a possible algorithm for glaucoma case detec-
tion at community and clinic levels. In a retrospective evaluation
of outreach in Ibadan, people referred from outreach were
twice as likely to have mild/moderate glaucoma than patients
referred from other facilities who had more severe disease.26
Another strategy is to integrate optic disc imaging using
mobile phone apps into screening activities for non-
communicable diseases, or into programmes for the control of
onchocerciasis (river blindness) and trachoma, which are reach-
ing a high proportion of the most vulnerable population in
Nigeria.
Informal providers of healthcare, who are ubiquitous and
acceptable to community members in Africa, could also be
engaged in identifying individuals suspected of having glau-
coma. For example, in Nassarawa, spectacle vendors were
enrolled in a study to assess interventions for ﬁnding cases of
glaucoma in the community. About half of those referred by
spectacle vendors subsequently attended the eye clinic, 15% of
whom were newly diagnosed with glaucoma (personal commu-
nication: HI, MSc PHEC dissertation, LSHTM 2016).
Other approaches for earlier detection may include designing
and implementing a community awareness strategy, using local
terms such as those in Hausa that describe behaviour associated
with peripheral visual ﬁeld loss (eg, taka shanya), through social
and mass media platforms such as radio which has a wide reach,
television and newspapers. For example, people could be
encouraged to regularly check the vision of each eye by covering
the other eye. Community awareness strategies should be
planned carefully to avoid creating a demand that cannot be
met. However, greater demand is needed to generate political
pressure that may drive the development of better services.
STRENGTHENING HEALTH SYSTEM GOVERNANCE
A strong health system requires leadership and governance to
deliver improved care, based on evidence of what works, as
day-to-day monitoring and interval evaluation can improve ser-
vices. Additionally, it is important that team leaders take part in
developing policies to include glaucoma in national healthcare
Figure 2 Algorithm for glaucoma case detection at community and clinic levels by assessment of cup:disc ratio and relative afferent pupillary
defect.
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plans and to integrate eye care into programmes for non-
communicable diseases. Data and information are also required
for advocacy with policy makers and for the engagement of civil
society to improve health education, knowledge and public
awareness.
The associations of patients with glaucoma can be strength-
ened to support vulnerable groups through sharing experiences
and resources by patients and family advocates.
CONCLUSION
Glaucoma is a complex disease to manage and addressing it as a
public health problem is a challenge. However, we need to
change the paradigm to recognise that glaucoma is a potentially
avoidable cause of blindness in Africa. We have discussed pos-
sible ways in which to improve services for glaucoma in Nigeria
with the aim of ensuring inclusion of those most at risk of blind-
ness from glaucoma that is, the poor. Further clinical and oper-
ational research is required to address the acknowledged
evidence gaps. We also advocate for policies to make glaucoma
treatment available and affordable to all, and possibly free to
the poor. Rather than remaining silent, let us give patients with
glaucoma a voice so that the silent thief of sight does not lead
them into darkness.
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